Oscar Health, Inc. $OSCR Holdings Decreased by Northern Trust Corp

Key Points

• Northern Trust Corp has reduced its stake in Oscar Health, Inc. by 1.3%, now owning approximately 1.92 million shares worth about $25.2 million.
• Several institutional investors have recently adjusted their holdings in Oscar Health, with significant increases from American Century Companies (50% increase) and new positions taken by Cresset Asset Management and Nuveen LLC.
• Oscar Health's stock is currently rated as a Strong Sell by analysts, with a consensus price target of $12.07, down from previous targets of up to $28.00.

Northern Trust Corp cut its position in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 1.3% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,922,219 shares of the company's stock after selling 25,560 shares during the quarter. Northern Trust Corp owned approximately 0.77% of Oscar Health worth $25,200,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Tempus Wealth Planning LLC lifted its holdings in Oscar Health by 6.7% in the first quarter. Tempus Wealth Planning LLC now owns 14,392 shares of the company's stock valued at $189,000 after acquiring an additional 906 shares during the period. Xponance Inc. boosted its holdings in Oscar Health by 7.1% during the 1st quarter. Xponance Inc. now owns 15,423 shares of the company's stock valued at $202,000 after acquiring an additional 1,029 shares during the period. CWM LLC boosted its stake in shares of Oscar Health by 50.7% in the 1st quarter. CWM LLC now owns 3,204 shares of the company's stock valued at $42,000 after buying an additional 1,078 shares during the period. Oppenheimer & Co. Inc. lifted its stake in Oscar Health by 4.6% during the first quarter. Oppenheimer & Co. Inc. now owns 28,362 shares of the company's stock worth $372,000 after purchasing an additional 1,250 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC increased its position in Oscar Health by 15.2% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 13,862 shares of the company's stock worth $186,000 after buying an additional 1,834 shares during the period. Hedge funds and other institutional investors own 75.70% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have recently commented on OSCR. UBS Group restated a "sell" rating and set a $11.00 price target (down previously from $15.00) on shares of Oscar Health in a research note on Tuesday, July 15th. Raymond James Financial lowered Oscar Health from an "outperform" rating to a "market perform" rating in a report on Tuesday, June 24th. Wells Fargo & Company lowered Oscar Health from an "equal weight" rating to an "underweight" rating and decreased their price objective for the company from $16.00 to $10.00 in a research note on Friday, July 11th. Baird R W downgraded Oscar Health from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 25th. Finally, Wall Street Zen downgraded Oscar Health from a "hold" rating to a "sell" rating in a research report on Saturday, August 9th. Four research analysts have rated the stock with a Hold rating and five have given a Sell rating to the company. According to data from MarketBeat.com, Oscar Health has an average rating of "Strong Sell" and an average price target of $12.07.

Oscar Health Stock Performance

NYSE:OSCR traded down $0.23 during midday trading on Tuesday, reaching $16.44. 14,063,324 shares of the company traded hands, compared to its average volume of 17,454,616. The company has a fifty day moving average price of $15.88 and a 200 day moving average price of $14.93. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.86 and a quick ratio of 0.86. The firm has a market capitalization of $4.25 billion, a price-to-earnings ratio of -20.29 and a beta of 1.87. Oscar Health, Inc. has a twelve month low of $11.20 and a twelve month high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, beating the consensus estimate of ($0.90) by $0.01. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The firm had revenue of $2.86 billion for the quarter, compared to the consensus estimate of $2.88 billion. During the same quarter in the previous year, the business earned $0.20 EPS. The firm's revenue for the quarter was up 29.0% on a year-over-year basis. On average, analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.